Skip to main content
Canadian Medical Association Journal logoLink to Canadian Medical Association Journal
. 1959 Sep 15;81(6):470–477.

SUSTAINED RELEASE OF DRUGS IN CERTAIN DRUG-RESIN COMPLEXES AS JUDGED BY URINARY EXCRETION RATES *

D G Chapman, K G Shenoy, J A Campbell
PMCID: PMC1831229  PMID: 13809222

Full text

PDF
470

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ABRAHAMS A., LINNELL W. H. Oral depot therapy with a new long-acting dexamphetamine salt. Lancet. 1957 Dec 28;273(7009):1317–1318. doi: 10.1016/s0140-6736(57)91641-0. [DOI] [PubMed] [Google Scholar]
  2. CAMPBELL J. A., CHAPMAN D. G., CHATTEN L. G. Physiological availability of drugs in tablets. Can Med Assoc J. 1957 Jan 15;76(2):102–106. [PMC free article] [PubMed] [Google Scholar]
  3. CAMPBELL J. A., CHAPMAN D. G., CHATTEN L. G. Timed disintegration medication; need for more quantitative criteria. Can Med Assoc J. 1957 Sep 15;77(6):602–603. [PMC free article] [PubMed] [Google Scholar]
  4. CHAUDHRY N. C., SAUNDERS L. Sustained release of drugs from ion exchange resins. J Pharm Pharmacol. 1956 Nov;8(11):975-83; discussion, 983-6. doi: 10.1111/j.2042-7158.1956.tb12227.x. [DOI] [PubMed] [Google Scholar]
  5. CRAMPTON J. M., VOSS E. Salicylamide I. Absorption, excretion, and blood levels. J Am Pharm Assoc Am Pharm Assoc. 1954 Aug;43(8):470–473. doi: 10.1002/jps.3030430808. [DOI] [PubMed] [Google Scholar]
  6. FREED S. C., KEATING J. W., HAYS E. E. Amphetamine-resin complex for prolonged appetite suppression. Ann Intern Med. 1956 Jun;44(6):1136–1141. doi: 10.7326/0003-4819-44-6-1136. [DOI] [PubMed] [Google Scholar]
  7. KELLER R. E., ELLENBOGEN W. C. The determination of d-amphetamine in body fluids. J Pharmacol Exp Ther. 1952 Sep;106(1):77–82. [PubMed] [Google Scholar]
  8. NELSON E. A note on mathematics of oral sustained release products. J Am Pharm Assoc Am Pharm Assoc. 1957 Sep;46(9):572–573. doi: 10.1002/jps.3030460918. [DOI] [PubMed] [Google Scholar]
  9. SWINTOSKY J. V. Illustrations and pharmaceutical interpretations of first order drug elimination rate from the bloodstream. J Am Pharm Assoc Am Pharm Assoc. 1956 Jun;45(6):395–400. doi: 10.1002/jps.3030450614. [DOI] [PubMed] [Google Scholar]
  10. SWINTOSKY J. V., ROBINSON M. J., FOLTZ E. L., FREE S. M. Sulfaethylthiadiazole. I. Interpretations of human blood level concentrations following oral doses. J Am Pharm Assoc Am Pharm Assoc. 1957 Jul;46(7):399–403. [PubMed] [Google Scholar]
  11. TRINDER P. Rapid determination of salicylate in biological fluids. Biochem J. 1954 Jun;57(2):301–303. doi: 10.1042/bj0570301. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES